LONDON, Mar 9: An anti-inflammatory drug normally used to treat rheumatoid arthritis reduces the risk of death when given to hospitalised patients with severe COVID-19, according to a study led by researchers at the University of Oxford. The benefit of baricitinib is in addition to those of dexamethasone and tocilizumab, two other anti-inflammatory treatments which have previously been shown to reduce the risk of death in these patients, the researchers said. “It is now well-established that in people admitted to hospital […]
Is antibody cocktail offering the right mix? biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
How drugs dished out by GPs for everything from head lice to diabetes could be the future of fighting Covid telegraph.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraph.co.uk Daily Mail and Mail on Sunday newspapers.